Current Understanding and Future Perspectives on Hyperprogressive Disease Highlight the Tumor Microenvironment.

导出原文传递

翻译打印收藏纠错

第一作者： Meiqi,Li

第一单位： Laboratory of Molecular Pharmacology, Department of Pharmacology, School of Pharmacy, Southwest Medical University, Luzhou, Sichuan, China.

作者： Meiqi,Li ^[1] ; Xianmei,Zhong ^[2] ; Fukuan,Du ^[3] ; Xu,Wu ^[1] ; Mingxing,Li ^[2] ; Yu,Chen ^[3] ; Yueshui,Zhao ^[1] ; Jing,Shen ^[2] ; Zhongming,Yang ^[3] ; Zhangang,Xiao ^[1]

作者单位： Laboratory of Molecular Pharmacology, Department of Pharmacology, School of Pharmacy, Southwest Medical University, Luzhou, Sichuan, China. ^[1] Cell Therapy & Cell Drugs of Luzhou Key Laboratory, Luzhou, Sichuan, China. ^[2] South Sichuan Institute of Translational Medicine, Luzhou, Sichuan, China. ^[3] Department of Oncology and Hematology, The Affiliated Traditional Chinese Medicine Hospital of Southwest Medical University, Luzhou, Sichuan, China. ^[4]

关键词 PD-1 PD-L1 hyperprogressive disease immune checkpoint inhibitors immunotherapy response evaluation criteria in solid tumors tumor microenvironment

主题词疾病恶化(Disease Progression);人类(Humans);免疫疗法(Immunotherapy);肿瘤(Neoplasms);肿瘤微环境(Tumor Microenvironment)

DOI 10.1002/jcph.2048

PMID 35303368

发布时间 2022-08-18

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交